Circulating microRNAs vs. aortic diameter in bicuspid aortic valve aortopathy
Standard
Circulating microRNAs vs. aortic diameter in bicuspid aortic valve aortopathy. / Naito, Shiho; Petersen, Johannes; Sequeira-Gross, Tatiana; Zeller, Tanja; Reichenspurner, Hermann; Girdauskas, Evaldas.
in: ASIAN CARD THORAC AN, Jahrgang 30, Nr. 8, 10.2022, S. 947-953.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Circulating microRNAs vs. aortic diameter in bicuspid aortic valve aortopathy
AU - Naito, Shiho
AU - Petersen, Johannes
AU - Sequeira-Gross, Tatiana
AU - Zeller, Tanja
AU - Reichenspurner, Hermann
AU - Girdauskas, Evaldas
PY - 2022/10
Y1 - 2022/10
N2 - There is growing clinical need and interest to implement novel risk prediction tools in bicuspid aortic valve-associated proximal aortic disease, so-called bicuspid aortic valve aortopathy. Inherent limitations of the diameter-based risk stratification for adverse aortic events in bicuspid aortic valve aortopathy patients have recently been recognized. Therefore, alternative diagnostic tools and subsequent adjustments in the treatment guidelines are urgently needed. Herein, we summarize the current evidence on recent diagnostic developments to improve risk stratification in bicuspid aortic valve aortopathy, including circulating microRNAs as biomarkers to predict the progression of aortic disease.
AB - There is growing clinical need and interest to implement novel risk prediction tools in bicuspid aortic valve-associated proximal aortic disease, so-called bicuspid aortic valve aortopathy. Inherent limitations of the diameter-based risk stratification for adverse aortic events in bicuspid aortic valve aortopathy patients have recently been recognized. Therefore, alternative diagnostic tools and subsequent adjustments in the treatment guidelines are urgently needed. Herein, we summarize the current evidence on recent diagnostic developments to improve risk stratification in bicuspid aortic valve aortopathy, including circulating microRNAs as biomarkers to predict the progression of aortic disease.
U2 - 10.1177/0218492320927233
DO - 10.1177/0218492320927233
M3 - SCORING: Review article
C2 - 32498553
VL - 30
SP - 947
EP - 953
JO - ASIAN CARD THORAC AN
JF - ASIAN CARD THORAC AN
SN - 0218-4923
IS - 8
ER -